Publication Details

Metabolic tumor burden predicts for disease progression and death in lung cancer.

Lee P, Weerasuriya DK, Lavori PW, Quon A, Hara W, Maxim PG, Le QT, Wakelee HA, Donington JS, Graves EE, Loo BW. Int J Radiat Oncol Biol Phys. 2007; 69 (2): 328-33

In lung cancer, stage is an important prognostic factor for disease progression and survival. However, stage may be simply a surrogate for underlying tumor burden. Our purpose was to assess the prognostic value of tumor burden measured by 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging.

PubMedID: 17869659